Roszell Iii Mack Net Worth

What's Roszell Mack's mailing address?

Roszell's mailing address filed with the SEC is 1200 SUMMIT AVE, SUITE 414, FORT WORTH, TX, 76102.

Insiders trading at Sanara MedTech

Over the last 5 years, insiders at Sanara MedTech have traded over $168,795 worth of Sanara MedTech stock. The most active insiders traders include Eric D Tanzberger, Ronald T Nixon és James W Stuckert. On average, Sanara MedTech executives and independent directors trade stock every 55 days with the average trade being worth of $25,133. The most recent stock trade was executed by Michael D. Mc Neil on 12 April 2023, trading 1,000 units of SMTI stock currently worth $6,000.

What does Sanara MedTech do?

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Sanara MedTech executives and stock owners

Sanara MedTech executives and other stock owners filed with the SEC include:

• Zachary B. Fleming,
  Chief Exec. Officer
• Shawn M. Bowman,
  Co-COO & Pres of Wound Care
• Michael D. McNeil,
  CFO & Corp. Sec.
• Cathy Bradshaw,
  President of Wound Care Innovations, LLC
• Kenneth Thorpe,
  Director
• Ann Salamone,
  Director
• Robert DeSutter,
  Director
• Zachary Fleming,
  Co-Chief Operating Officers
• Shawn Bowman,
  Co-Chief Operating Officers
• Michael McNeil,
  Chief Financial Officer
• J Carmena,
  Principal Executive Officer, Director
• Ronald Nixon,
  Executive Chairman of the Board
• Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D.,
  Pres of Telehealth Services
• Carla Day,
  Director of Customer & Sales Services
• Tricia Matteson,
  Sr. Director of Marketing
• Dr. Jane A. Fore,
  Chief Medical Officer
• Bill Fitzgerald,
  Compliance Officer
• Callon Nichols,
  Director of Investor Relations
• Ronald T. Nixon,
  Exec. Chairman
• Roszell Iii Mack,
  Director
• Christopher A. Morrison,
  President - Telehealth Svcs.
• Jacob A. Waldrop,
  Chief Operating Officer
• Eric D Major,
  Director
• Eric D Tanzberger,
  Director
• Sara N Ortwein,
  Director
• Rebecca E Mc Mahon,
  President - R&D
• James W Stuckert,
  Director